Site Selection
Investigator site selection is a critical element of a successful clinical trial. Clinilabs Drug Development Corporation offers an expansive network of investigator sites in 42 countries, with a robust operational infrastructure that supports international multicenter trials and independent, engaged investigators who have been pre-identified for their access to patients with CNS disorders, providing your study with a virtual waiting room. Clinilabs has deep-rooted, long-standing relationships with these researchers, who consistently exceed expectations for subject accrual and diversity, data quality, and timelines while maintaining a patient-centric approach.
I have no ideology. My ideology is health.
All truths are easy to understand once they are discovered; the point is to discover them.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
The reward for work well done is the opportunity to do more.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
If you think compliance is expensive, try non-compliance.
Good information is the best medicine.
There is so much more to be done; the patients are waiting.
One never notices what has been done; one can only see what remains to be done.
One sometimes finds what one is not looking for.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
The pace of discovery is going unbelievably fast.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
Drugs don’t work in patients who don’t take them.
I am not accustomed to saying anything with certainty after only one or two observations.
The best way to predict the future is to invent it.